AU4066900A - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- AU4066900A AU4066900A AU40669/00A AU4066900A AU4066900A AU 4066900 A AU4066900 A AU 4066900A AU 40669/00 A AU40669/00 A AU 40669/00A AU 4066900 A AU4066900 A AU 4066900A AU 4066900 A AU4066900 A AU 4066900A
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/12—Eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12725099P | 1999-03-31 | 1999-03-31 | |
| US60127250 | 1999-03-31 | ||
| PCT/US2000/008833 WO2000058296A1 (en) | 1999-03-31 | 2000-03-31 | Protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4066900A true AU4066900A (en) | 2000-10-16 |
Family
ID=22429122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU40669/00A Abandoned AU4066900A (en) | 1999-03-31 | 2000-03-31 | Protease inhibitors |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1173429A4 (es) |
| JP (1) | JP2002540199A (es) |
| AU (1) | AU4066900A (es) |
| CO (1) | CO5180536A1 (es) |
| HK (1) | HK1044758A1 (es) |
| PE (1) | PE20001607A1 (es) |
| UY (1) | UY26088A1 (es) |
| WO (1) | WO2000058296A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| EP1229914A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
| JP2003513972A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテアーゼ阻害剤 |
| AU1588901A (en) | 1999-11-10 | 2001-06-06 | Smithkline Beecham Corporation | Protease inhibitors |
| KR20020082896A (ko) | 2000-03-21 | 2002-10-31 | 스미스클라인 비참 코포레이션 | 프로테아제 억제제 |
| JP2005515254A (ja) | 2002-01-17 | 2005-05-26 | スミスクライン ビーチャム コーポレーション | カテプシンk阻害剤として有用なシクロアルキルケトアミド誘導体 |
| JP2004196696A (ja) * | 2002-12-18 | 2004-07-15 | Kyowa Hakko Kogyo Co Ltd | 関節炎の予防剤または治療剤 |
| CN113651795B (zh) * | 2021-09-14 | 2022-09-02 | 江西开源香料有限公司 | 一种西瓜酮的合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5374623A (en) * | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
-
2000
- 2000-03-29 UY UY26088A patent/UY26088A1/es not_active Application Discontinuation
- 2000-03-31 WO PCT/US2000/008833 patent/WO2000058296A1/en not_active Ceased
- 2000-03-31 AU AU40669/00A patent/AU4066900A/en not_active Abandoned
- 2000-03-31 PE PE2000000283A patent/PE20001607A1/es not_active Application Discontinuation
- 2000-03-31 EP EP00920078A patent/EP1173429A4/en not_active Withdrawn
- 2000-03-31 HK HK02104641.3A patent/HK1044758A1/zh unknown
- 2000-03-31 CO CO00023372A patent/CO5180536A1/es not_active Application Discontinuation
- 2000-03-31 JP JP2000607999A patent/JP2002540199A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| HK1044758A1 (zh) | 2002-11-01 |
| EP1173429A1 (en) | 2002-01-23 |
| EP1173429A4 (en) | 2002-06-19 |
| JP2002540199A (ja) | 2002-11-26 |
| WO2000058296A1 (en) | 2000-10-05 |
| CO5180536A1 (es) | 2002-07-30 |
| PE20001607A1 (es) | 2001-03-07 |
| UY26088A1 (es) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU6007200A (en) | Cysteine protease inhibitors | |
| AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
| AU4723799A (en) | Protease inhibitors | |
| AU7139598A (en) | Protease inhibitors | |
| AU4092799A (en) | Protease inhibitors | |
| AU1393900A (en) | Morpholino-ethoxybenzofuran protease inhibitors | |
| AU9110298A (en) | Protease inhibitors | |
| EP1235577A4 (en) | PROTEASE INHIBITORS | |
| AU7126900A (en) | Enzyme inhibitors | |
| AU1588901A (en) | Protease inhibitors | |
| AU3235100A (en) | Prothease inhibitors | |
| AU1474801A (en) | Protease inhibitors | |
| AU4564499A (en) | Protease inhibitors | |
| AU2713100A (en) | Protease inhibitors | |
| EP1229912A4 (en) | PROTEASE INHIBITORS | |
| EP1231921A4 (en) | PROTEASE INHIBITORS | |
| EP1229915A4 (en) | PROTEASE INHIBITORS | |
| AU3888200A (en) | Protease inhibitors | |
| AU1474701A (en) | Protease inhibitors | |
| AU1474601A (en) | Protease inhibitors | |
| AU4066900A (en) | Protease inhibitors | |
| AU9300298A (en) | Protease inhibitors | |
| EP1229911A4 (en) | PROTEASE INHIBITORS | |
| EP1231923A4 (en) | PROTEASE INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |